Skip to main content
Equibles
HUM logo

HUM · Humana Inc · Metrics

Track HUM — free

Use HUM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HUM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$411.87 -2.98 (-0.72%) At close · Oct 28 Q2 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$49.81B
Shares
120.06M
Volume · Oct 28 1.05M Avg daily vol (3M) 1.33M

HUM metrics

113 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$411.87
Market cap
$49.81B

Price action

20 metrics
Price change (1W)
-2.9%
Price change (30D)
+6.5%
Price change (3M)
+6.7%
Price change (6M)
+80.6%
Price change (YTD)
+62.0%
Price change (1Y)
+41.9%
Trailing year
Price change (5Y)
-9.5%
52-week high
$433.50
52-week low
$163.67
Change from 52-week high
-4.3%
Change from 52-week low
+153.5%
Annualized volatility
46.8%
Annualized volatility (3M)
40.3%
Beta
0.6
RSI (14D)
52.7
Price vs SMA 50
+4.0%
Price vs SMA 200
+35.5%
Avg volume (3M)
1.34M
Relative volume
0.5
Average dollar volume
$530.61M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
120.06M

Valuation

12 metrics
P / E (TTM)
39.2
Trailing earnings · reciprocal yield 2.6%
PEG ratio
1.4
EV / revenue
0.3×
reciprocal yield 360.0%
EV / EBITDA
12.0×
reciprocal yield 8.3%
EV / EBIT
15.0×
reciprocal yield 6.7%
P / sales
0.3×
reciprocal yield 290.8%
P / book
2.6
reciprocal yield 38.4%
FCF yield
3.9%
TTM · current market cap
Buyback yield
0.3%
P / FCF
25.7
reciprocal yield 3.9%
P / operating cash flow
19.7
reciprocal yield 5.1%
Earnings yield
2.6%

Historical valuation

8 metrics
P / E historical average (3Y)
23.3×
reciprocal yield 4.3%
P / E historical average (5Y)
22.6×
reciprocal yield 4.4%
EV / revenue historical average (3Y)
0.2×
reciprocal yield 414.0%
EV / revenue historical average (5Y)
0.4×
reciprocal yield 274.3%
EV / EBIT historical average (3Y)
8.5×
reciprocal yield 11.8%
EV / EBIT historical average (5Y)
11.0×
reciprocal yield 9.1%
EV / EBITDA historical average (3Y)
6.6×
reciprocal yield 15.1%
EV / EBITDA historical average (5Y)
6.6×
reciprocal yield 15.1%

Dividends & buybacks

7 metrics
Dividend yield
0.6%
Trailing 12 months
Payout ratio
33.6%
Shareholder yield
1.2%
Dividend / share (TTM)
$2.66
Dividend growth YoY
-25.0%
Dividend growth streak
0
Last ex-dividend
2026-06-26

Earnings calendar

2 metrics
Next earnings
2026-11-06
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
—
Operating margin
1.9%
Trailing 12 months
Net margin
0.9%
Gross profit (TTM)
—
Operating profit (TTM)
$2.71B
Net income (TTM)
$1.28B
Trailing 12 months
Diluted EPS (TTM)
$10.59
FCF margin
1.3%
Effective tax rate
19.2%

Per share

11 metrics
Revenue per diluted share (TTM)
$1,205.16
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$22.40
EBITDA per diluted share (TTM)
$27.85
Net income per diluted share (TTM)
$10.59
Operating cash flow per diluted share (TTM)
$21.01
Free cash flow per diluted share (TTM)
$16.13
Capital expenditures per diluted share (TTM)
$4.88
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$2.04
Book value per share
$154.75

Growth

11 metrics
Revenue growth YoY
+26.2%
Year over year
Net income growth YoY
+27.3%
Revenue (TTM)
$145.68B
Trailing 12 months
EPS growth YoY
+27.1%
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
+11.8%
Revenue CAGR (5Y)
+10.9%
EPS CAGR (3Y)
-23.6%
EPS CAGR (5Y)
-17.2%
FCF CAGR (3Y)
-52.3%
FCF CAGR (5Y)
-39.6%

Quality

14 metrics
Return on equity
6.7%
Return on assets
2.2%
Debt / equity
0.7
Current ratio
1.7
EBITDA (TTM)
$3.37B
Free cash flow (TTM)
$1.95B
Quick ratio
1.7
Interest coverage
3.8
Net debt / EBITDA
-2.9
Return on invested capital
22.8%
Trailing 12 months
Net cash
$9.62B
Latest balance sheet
Cash & equivalents
$6.89B
Total assets
$57.20B
Total debt
$14.25B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.54B
Capital expenditures (TTM)
$590.00M
R&D (TTM)
—
SG&A (TTM)
$16.52B
Stock compensation (TTM)
$247.00M
R&D / revenue
—
Stock compensation / revenue
0.2%

Ownership (13F)

9 metrics
13F filers
940
13F filer change QoQ
+145
Institutional ownership
104.5%
Conviction holders (share of 13F filers)
1.8%
Crowding (high-turnover and private-fund holders)
35.8%
Private-fund adviser ownership
35.4%
Active holders' share change QoQ
+1.2%
Holder tenure
14.7
Price vs estimated holder cost
+42.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.3%

Short interest

3 metrics
Short interest
3.1%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 49071 CUSIP 444859102 13F (30d) 279 filings 262 filers Visit website Investor relations